| __timestamp | Cytokinetics, Incorporated | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 7461000 |
| Thursday, January 1, 2015 | 19667000 | 11960000 |
| Friday, January 1, 2016 | 27823000 | 13108000 |
| Sunday, January 1, 2017 | 36468000 | 17501000 |
| Monday, January 1, 2018 | 31282000 | 22472000 |
| Tuesday, January 1, 2019 | 39610000 | 24286000 |
| Wednesday, January 1, 2020 | 52820000 | 29689000 |
| Friday, January 1, 2021 | 96803000 | 38837000 |
| Saturday, January 1, 2022 | 177977000 | 47489000 |
| Sunday, January 1, 2023 | 173612000 | 53379000 |
Unleashing insights
In the ever-evolving biotech industry, operational efficiency is key to success. Over the past decade, Cytokinetics, Incorporated and Xencor, Inc. have demonstrated contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. Cytokinetics has seen a staggering increase of over 900% in SG&A costs from 2014 to 2023, peaking in 2022. This surge reflects their aggressive expansion and investment in operational capabilities. In contrast, Xencor's SG&A expenses have grown more modestly, approximately 615% over the same period, indicating a more conservative approach to scaling operations.
These trends highlight the strategic differences between the two companies. While Cytokinetics appears to be investing heavily in growth, Xencor maintains a steady, controlled expansion. As the biotech landscape continues to shift, these operational strategies will play a crucial role in determining each company's future success.
Comparing SG&A Expenses: Merck & Co., Inc. vs Xencor, Inc. Trends and Insights
Comparing SG&A Expenses: Novartis AG vs Cytokinetics, Incorporated Trends and Insights
Breaking Down SG&A Expenses: Viatris Inc. vs Cytokinetics, Incorporated
Summit Therapeutics Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Who Optimizes SG&A Costs Better? Cytokinetics, Incorporated or TG Therapeutics, Inc.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Cost of Revenue Trends: Cytokinetics, Incorporated vs Xencor, Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Xencor, Inc.